Takeda General Counsel Files Initial Ownership of 191,280 ADS
TAKEDA PHARMACEUTICAL CO LTD
Subscribe to track TAK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Takeda General Counsel Files Initial Ownership of 191,280 ADS
Company: TAKEDA PHARMACEUTICAL CO LTD (TAK) Form: 3 (Initial Statement) | Filed: 2026-03-18 Significance: Low
Insider: Furney Natalie Anne Marie Title: Global General Counsel | Relationship: Officer
Holdings Reported: • Security: American Depositary Shares • Shares: 191,280 • Ownership: Direct • Note: Represents RSU award vesting 2026-2028
Key Insight: New Global General Counsel discloses initial equity position consisting entirely of Restricted Stock Units (RSUs).
Market Context: Routine initial filing for new executive officer; represents approx 0.01% of outstanding shares.
Comprehensive Analysis
SEC Filing Analysis: TAKEDA PHARMACEUTICAL CO LTD (TAK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: New Global General Counsel establishes initial reporting position via RSU awards.
- Market Impact: Neutral; routine administrative filing for new officer.
Company Information
| Field | Value |
|---|---|
| Company | TAKEDA PHARMACEUTICAL CO LTD |
| Ticker Symbol | TAK |
| CIK | 0001395064 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Furney Natalie Anne Marie |
| CIK | 0002111535 |
| Title/Position | Global General Counsel |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3 (Initial Statement of Beneficial Ownership) |
| Filing Date | 2026-03-18 |
| Security Type | American Depositary Shares |
| Shares Reported | 191,280 |
| Price Per Share | N/A (Initial Holding) |
| Total Value | N/A |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Shares Reported | 191,280 |
| % of Shares Outstanding | 0.012% |
| Materiality Assessment | Low |
Impact Evaluation
- Ownership Concentration: The reported holding represents a negligible fraction (0.012%) of the 1.59 billion shares outstanding.
- Dilution Impact: The 191,280 RSUs represent minimal potential dilution to existing shareholders.
- Transaction Significance: As a Form 3 filing, this indicates the establishment of a reporting relationship rather than an active open market trade.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a standard compliance filing for a new executive. The holdings are RSUs (compensation) rather than open market purchases, signaling alignment with shareholders but no immediate market sentiment shift.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Vesting Schedule: The reported shares are RSUs vesting in three equal tranches on July 1 of 2026, 2027, and 2028.
- Nature of Filing: Form 3 is filed when a person first becomes an insider (officer, director, or 10% owner). It details their holdings at that specific moment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.